Summary
To investigate whether peroxisome proliferators-activated receptor-γ (PPARγ) ligand Troglitazone can reduce endothelial injury and activation during storage of harvested saphenous vein grafts. Segments of human saphenous vein graft were collected from 9 patients undergoing coronary bypass surgery and then divided into two equal parts of control and test specimens, were stored in either heparinized blood (control group) or heparinized blood containing 20 μmol/L troglitazone (test group) for 1 h at room temperature. Tissue distribution and protein expression of VCAM-1, ICAM-1, and endothelial nitric oxide synthase (eNOS) were compared using immunohistochemistry and Western blot analysis. Myeloperoxidase (MPO) activity, a marker of neutrophil sequestration in human saphenous vein grafts, was also measured in each group. The expression of ICAM-1 (753±132 versus 7201±934; P<0.01), VCAM-1 (3731±294 versus 8292±793; P<0.01), and MPO activity (1.52±0.42 U/g, 5.04±1.26 U/g P<0.01) were significantly lower in test group. In contract, eNOS expression (7983±834 versus 3989±1008; P<0.01) was significantly higher in test group. PPARγ ligand troglitazone might reduce endothelial injury during the storage period of human saphenous vein grafts.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Thatte H S, Khuri S F. The coronary artery bypass conduit: I. Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg, 2001,72:S2245–S2252
Hsueh W A, Jackson S, Law R E. Control of vascular cell proliferation and migration by PPAR Ɣ. Diabetes Care, 2001,24:392–397
Tsui J C, Souza D S, Filbey D et al. Preserved endothelial intergrity and nitric oxide synthase in saphenous vein grafts harvested by a “no-touch” technique. Br J Surg, 2001,88:1209–1215
Thatte H S, Biswas K S, Najjar S F et al. Multi-photon microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA. Ann Thorac Surg, 2003,75:1145–1152
Polikandriotis J A, Mazzella L J, Rupnow H L et al. Peroxisome proliferators-activated receptor γ ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferators-activated receptor γ-dependent mechanisms. Arterioscler Thromb Vasc Biol, 2005,25:1810–1816
Goya K, Sumitani S, Otsuki M et al. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells. J Diabetes Complications, 2006,20:336–342
Schaeffer U, Tanner B, Strohschneider T et al. Damage to arterial and venous endothelial cells in bypass grafts induced by several solution used in bypass surgery. Thoarc Cardiovasc Surg, 1997,45:168–171
Jackson S M, Parhami F, Xi X P et al. Peroxisome proliferators-activated receptor activators target human endothelial cells to inhibit leucocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol, 1999,19:2094–2506
Spoecker M, Darius H, Kaboth K et al. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol, 1998,63:732–739
Author information
Authors and Affiliations
Corresponding author
Additional information
The project was supported by a grant from the Health Ministry of Hubei Province (JX2B16).
Rights and permissions
About this article
Cite this article
Chen, S., Hu, Z., Zhang, K. et al. Effect of Troglitazone on expression of adhesion molecules and eNOS in human saphenous vein gaft. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 27, 657–659 (2007). https://doi.org/10.1007/s11596-007-0609-9
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-007-0609-9